276 related articles for article (PubMed ID: 22069624)
1. Consequences and utility of the zinc-dependent metalloprotease activity of anthrax lethal toxin.
Bromberg-White J; Lee CS; Duesbery N
Toxins (Basel); 2010 May; 2(5):1038-53. PubMed ID: 22069624
[TBL] [Abstract][Full Text] [Related]
2. The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity.
Tonello F; Montecucco C
Mol Aspects Med; 2009 Dec; 30(6):431-8. PubMed ID: 19665472
[TBL] [Abstract][Full Text] [Related]
3. Anthrax lethal factor inhibitors as potential countermeasure of the infection.
Kumar BV; Malik S; Grandhi P; Dayam R; Sarma JA
Curr Top Med Chem; 2014; 14(17):1977-89. PubMed ID: 25262802
[TBL] [Abstract][Full Text] [Related]
4. Exceptionally Selective Substrate Targeting by the Metalloprotease Anthrax Lethal Factor.
Turk BE
Adv Exp Med Biol; 2019; 1111():189-203. PubMed ID: 30267305
[TBL] [Abstract][Full Text] [Related]
5. Stop the killer: how to inhibit the anthrax lethal factor metalloprotease.
Montecucco C; Tonello F; Zanotti G
Trends Biochem Sci; 2004 Jun; 29(6):282-5. PubMed ID: 15276179
[TBL] [Abstract][Full Text] [Related]
6. Bacillus anthracis: a multi-faceted role for anthrax lethal toxin in thwarting host immune defenses.
Xu L; Frucht DM
Int J Biochem Cell Biol; 2007; 39(1):20-4. PubMed ID: 17008119
[TBL] [Abstract][Full Text] [Related]
7. Anthrax toxin: a tripartite lethal combination.
Ascenzi P; Visca P; Ippolito G; Spallarossa A; Bolognesi M; Montecucco C
FEBS Lett; 2002 Nov; 531(3):384-8. PubMed ID: 12435580
[TBL] [Abstract][Full Text] [Related]
8. Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity.
Klimpel KR; Arora N; Leppla SH
Mol Microbiol; 1994 Sep; 13(6):1093-100. PubMed ID: 7854123
[TBL] [Abstract][Full Text] [Related]
9. Insights into the anthrax lethal factor-substrate interaction and selectivity using docking and molecular dynamics simulations.
Dalkas GA; Papakyriakou A; Vlamis-Gardikas A; Spyroulias GA
Protein Sci; 2009 Aug; 18(8):1774-85. PubMed ID: 19585464
[TBL] [Abstract][Full Text] [Related]
10. Anthrax lethal factor cleaves regulatory subunits of phosphoinositide-3 kinase to contribute to toxin lethality.
Mendenhall MA; Liu S; Portley MK; O'Mard D; Fattah R; Szabo R; Bugge TH; Khillan JS; Leppla SH; Moayeri M
Nat Microbiol; 2020 Dec; 5(12):1464-1471. PubMed ID: 32895527
[TBL] [Abstract][Full Text] [Related]
11. An enzymatic electrochemiluminescence assay for the lethal factor of anthrax.
Rivera VR; Merrill GA; White JA; Poli MA
Anal Biochem; 2003 Oct; 321(1):125-30. PubMed ID: 12963063
[TBL] [Abstract][Full Text] [Related]
12. New insights into the pathogenesis and treatment of anthrax toxin-induced shock.
Li Y; Sherer K; Cui X; Eichacker PQ
Expert Opin Biol Ther; 2007 Jun; 7(6):843-54. PubMed ID: 17555370
[TBL] [Abstract][Full Text] [Related]
13. Anthrax Pathogenesis.
Moayeri M; Leppla SH; Vrentas C; Pomerantsev AP; Liu S
Annu Rev Microbiol; 2015; 69():185-208. PubMed ID: 26195305
[TBL] [Abstract][Full Text] [Related]
14. Lethal and edema toxins in the pathogenesis of Bacillus anthracis septic shock: implications for therapy.
Sherer K; Li Y; Cui X; Eichacker PQ
Am J Respir Crit Care Med; 2007 Feb; 175(3):211-21. PubMed ID: 17095744
[TBL] [Abstract][Full Text] [Related]
15. Anthrax, MEK and cancer.
Bodart JF; Chopra A; Liang X; Duesbery N
Cell Cycle; 2002 Jan; 1(1):10-5. PubMed ID: 12429903
[TBL] [Abstract][Full Text] [Related]
16. Metalloproteinase inhibitors, nonantimicrobial chemically modified tetracyclines, and ilomastat block Bacillus anthracis lethal factor activity in viable cells.
Kocer SS; Walker SG; Zerler B; Golub LM; Simon SR
Infect Immun; 2005 Nov; 73(11):7548-57. PubMed ID: 16239558
[TBL] [Abstract][Full Text] [Related]
17. Lethal toxin actions and their consequences.
Hanna P
J Appl Microbiol; 1999 Aug; 87(2):285-7. PubMed ID: 10475969
[TBL] [Abstract][Full Text] [Related]
18. Low molecular weight inhibitors of the protease anthrax lethal factor.
Dalkas GA; Papakyriakou A; Vlamis-Gardikas A; Spyroulias GA
Mini Rev Med Chem; 2008 Mar; 8(3):290-306. PubMed ID: 18336349
[TBL] [Abstract][Full Text] [Related]
19. The metalloproteolytic activity of the anthrax lethal factor is substrate-inhibited.
Tonello F; Ascenzi P; Montecucco C
J Biol Chem; 2003 Oct; 278(41):40075-8. PubMed ID: 12888555
[TBL] [Abstract][Full Text] [Related]
20. Anthrax lethal factor inhibition.
Shoop WL; Xiong Y; Wiltsie J; Woods A; Guo J; Pivnichny JV; Felcetto T; Michael BF; Bansal A; Cummings RT; Cunningham BR; Friedlander AM; Douglas CM; Patel SB; Wisniewski D; Scapin G; Salowe SP; Zaller DM; Chapman KT; Scolnick EM; Schmatz DM; Bartizal K; MacCoss M; Hermes JD
Proc Natl Acad Sci U S A; 2005 May; 102(22):7958-63. PubMed ID: 15911756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
